Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C6RD
|
|||
| Former ID |
DIB001667
|
|||
| Drug Name |
Ypeginterferon alfa-2b
|
|||
| Synonyms |
Ypeginterferon alfa-2b (chronic hepatitis B and C infections); Ypeginterferon alfa-2b (chronic hepatitis B and C infections), Amoytop; Ypeginterferon alfa-2b (chronic hepatitis B), Amoytop; Ypeginterferon alfa-2b (chronic hepatitis C), Amoytop; YPEG-rhIFN alpha-2b (chronic hepatitis B, C infections), Amoytop
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2 | [1] | |
| Company |
Xiamen Amoytop Biotech Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01140997) Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.